vs
ESCALADE INC（ESCA）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是ESCALADE INC的1.1倍（$69.8M vs $62.6M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 5.9%，领先378.1%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -2.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 4.5%）
Escalade Inc是一家专业体育用品制造及分销商，主营篮球架、射箭装备、乒乓球器材、游戏桌及户外休闲配件，核心市场覆盖北美、欧洲及亚太地区，服务客户涵盖零售消费、商业健身、专业体育分销等领域。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
ESCA vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.1倍
$62.6M
营收增速更快
RIGL
高出23.4%
-2.2%
净利率更高
RIGL
高出378.1%
5.9%
两年增速更快
RIGL
近两年复合增速
4.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.6M | $69.8M |
| 净利润 | $3.7M | $268.1M |
| 毛利率 | 27.7% | 91.5% |
| 营业利润率 | 8.2% | 33.2% |
| 净利率 | 5.9% | 384.0% |
| 营收同比 | -2.2% | 21.2% |
| 净利润同比 | 37.1% | 1769.2% |
| 每股收益（稀释后） | $0.27 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESCARIGL
| Q4 25 | $62.6M | $69.8M | ||
| Q3 25 | $67.8M | $69.5M | ||
| Q2 25 | $54.3M | $101.7M | ||
| Q1 25 | $55.5M | $53.3M | ||
| Q4 24 | $63.9M | $57.6M | ||
| Q3 24 | $67.7M | $55.3M | ||
| Q2 24 | $62.5M | $36.8M | ||
| Q1 24 | $57.3M | $29.5M |
净利润ESCARIGL
| Q4 25 | $3.7M | $268.1M | ||
| Q3 25 | $5.6M | $27.9M | ||
| Q2 25 | $1.8M | $59.6M | ||
| Q1 25 | $2.6M | $11.4M | ||
| Q4 24 | $2.7M | $14.3M | ||
| Q3 24 | $5.7M | $12.4M | ||
| Q2 24 | $2.8M | $-1.0M | ||
| Q1 24 | $1.8M | $-8.2M |
毛利率ESCARIGL
| Q4 25 | 27.7% | 91.5% | ||
| Q3 25 | 28.1% | 93.2% | ||
| Q2 25 | 24.7% | 95.6% | ||
| Q1 25 | 26.7% | 91.7% | ||
| Q4 24 | 24.9% | 89.9% | ||
| Q3 24 | 24.8% | 85.5% | ||
| Q2 24 | 24.2% | 92.4% | ||
| Q1 24 | 25.0% | 93.1% |
营业利润率ESCARIGL
| Q4 25 | 8.2% | 33.2% | ||
| Q3 25 | 10.8% | 40.9% | ||
| Q2 25 | 4.8% | 60.1% | ||
| Q1 25 | 6.6% | 23.9% | ||
| Q4 24 | 7.1% | 28.9% | ||
| Q3 24 | 11.8% | 25.4% | ||
| Q2 24 | 7.1% | 1.2% | ||
| Q1 24 | 5.3% | -23.6% |
净利率ESCARIGL
| Q4 25 | 5.9% | 384.0% | ||
| Q3 25 | 8.2% | 40.2% | ||
| Q2 25 | 3.4% | 58.6% | ||
| Q1 25 | 4.7% | 21.5% | ||
| Q4 24 | 4.2% | 24.9% | ||
| Q3 24 | 8.4% | 22.5% | ||
| Q2 24 | 4.5% | -2.8% | ||
| Q1 24 | 3.1% | -27.9% |
每股收益（稀释后）ESCARIGL
| Q4 25 | $0.27 | $14.11 | ||
| Q3 25 | $0.40 | $1.46 | ||
| Q2 25 | $0.13 | $3.28 | ||
| Q1 25 | $0.19 | $0.63 | ||
| Q4 24 | $0.20 | $0.82 | ||
| Q3 24 | $0.40 | $0.70 | ||
| Q2 24 | $0.20 | $-0.06 | ||
| Q1 24 | $0.13 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | $18.5M | $52.5M |
| 股东权益账面价值 | $173.2M | $391.5M |
| 总资产 | $222.1M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.11× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ESCARIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务ESCARIGL
| Q4 25 | $18.5M | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | $25.6M | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益ESCARIGL
| Q4 25 | $173.2M | $391.5M | ||
| Q3 25 | $172.3M | $117.6M | ||
| Q2 25 | $168.3M | $81.9M | ||
| Q1 25 | $168.8M | $18.6M | ||
| Q4 24 | $169.0M | $3.3M | ||
| Q3 24 | $170.1M | $-14.6M | ||
| Q2 24 | $166.0M | $-29.9M | ||
| Q1 24 | $164.7M | $-31.7M |
总资产ESCARIGL
| Q4 25 | $222.1M | $513.6M | ||
| Q3 25 | $232.5M | $242.5M | ||
| Q2 25 | $218.3M | $206.7M | ||
| Q1 25 | $222.1M | $176.0M | ||
| Q4 24 | $226.3M | $164.0M | ||
| Q3 24 | $244.9M | $139.4M | ||
| Q2 24 | $243.1M | $128.4M | ||
| Q1 24 | $256.3M | $126.5M |
负债/权益比ESCARIGL
| Q4 25 | 0.11× | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | 0.15× | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.9M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $13.7M | — |
| 自由现金流率自由现金流/营收 | 21.8% | — |
| 资本支出强度资本支出/营收 | 2.0% | — |
| 现金转化率经营现金流/净利润 | 4.02× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $28.5M | — |
8季度趋势，按日历期对齐
经营现金流ESCARIGL
| Q4 25 | $14.9M | $22.0M | ||
| Q3 25 | $-965.0K | $24.0M | ||
| Q2 25 | $13.3M | $30.5M | ||
| Q1 25 | $3.8M | $-893.0K | ||
| Q4 24 | $12.3M | $14.5M | ||
| Q3 24 | $10.5M | $21.7M | ||
| Q2 24 | $13.3M | $302.0K | ||
| Q1 24 | $7.0K | $-5.0M |
自由现金流ESCARIGL
| Q4 25 | $13.7M | — | ||
| Q3 25 | $-1.3M | — | ||
| Q2 25 | $12.9M | — | ||
| Q1 25 | $3.2M | — | ||
| Q4 24 | $11.7M | — | ||
| Q3 24 | $10.2M | — | ||
| Q2 24 | $12.5M | — | ||
| Q1 24 | $-350.0K | — |
自由现金流率ESCARIGL
| Q4 25 | 21.8% | — | ||
| Q3 25 | -1.9% | — | ||
| Q2 25 | 23.7% | — | ||
| Q1 25 | 5.9% | — | ||
| Q4 24 | 18.4% | — | ||
| Q3 24 | 15.0% | — | ||
| Q2 24 | 20.0% | — | ||
| Q1 24 | -0.6% | — |
资本支出强度ESCARIGL
| Q4 25 | 2.0% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | 0.6% | — |
现金转化率ESCARIGL
| Q4 25 | 4.02× | 0.08× | ||
| Q3 25 | -0.17× | 0.86× | ||
| Q2 25 | 7.28× | 0.51× | ||
| Q1 25 | 1.45× | -0.08× | ||
| Q4 24 | 4.55× | 1.01× | ||
| Q3 24 | 1.85× | 1.75× | ||
| Q2 24 | 4.67× | — | ||
| Q1 24 | 0.00× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
